Company Filing History:
6 out of 1,373 
4 out of 1,209 
4 out of 505 
Years Active: 2000-2016
Title: Innovations and Contributions of Jonathan A. Fletcher
Introduction
Jonathan A. Fletcher is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of cancer research and treatment, holding a total of 7 patents. His work focuses on developing methods and compositions that enhance the diagnosis and treatment of cancer.
Latest Patents
Fletcher's latest patents include groundbreaking inventions such as "Methods and compositions for diagnosing and treating cancer." This invention provides assays, methods, systems, compositions, and kits aimed at diagnosing and treating cancer effectively. Another notable patent is "Platelet derived growth factor receptor alpha (PDGFRA) polypeptides comprising activating mutation(s)." This disclosure presents tyrosine kinase protein and nucleic acid variants, particularly PDGFRA variants, which are linked to neoplasms and the progression of cancer. The methods of diagnosis and prognosis, along with the development of new therapeutic agents using these molecules, are also covered in this patent.
Career Highlights
Throughout his career, Jonathan A. Fletcher has worked with esteemed institutions such as Brigham and Women's Hospital, Inc. and Dana-Farber Cancer Institute Inc. His research has significantly impacted the understanding and treatment of cancer, making him a key figure in the medical community.
Collaborations
Fletcher has collaborated with notable professionals in the field, including George Daniel Demetri and Michael C. Heinrich. These collaborations have further advanced his research and innovations in cancer treatment.
Conclusion
Jonathan A. Fletcher's contributions to cancer research through his patents and collaborations highlight his dedication to improving patient outcomes. His work continues to influence the field and inspire future innovations in cancer diagnosis and treatment.